Biologics

Harnessing the power of the immune system to deliver highly targeted therapies. Our biologics platform focuses on next-generation monoclonal antibodies and precision ADCs designed to seek and destroy cancer cells with unprecedented accuracy.

Specific Technologies

Anti-PD-1 Monoclonal Antibody

FRα Antibody Drug Conjugate (ADC)

TROP2 Antibody DrugConjugate (ADC)